Skip to main content
Download PDF

Immuno-protective response of Asian seabass (Lates calcarifer) to inactivated vaccines against Streptococcus iniae and Vibrio harveyi

BMC Veterinary Research volume 20, Article number: 89 (2024) Cite this article

Abstract

Background

In this study, the protective immunity and immunogenicity of the monovalent and bivalent Streptococcus iniae and Vibrio harveyi vaccine were evaluated in Asian seabass. To analyze immune responses, 1200 Asian seabass with an average weight of 132.6 ± 25.4 g were divided into eight treatments in triplicates (50 fish per tank) as follows: S. iniae immunized by injection (SI), V. harveyi immunized by injection (VI), bivalent S. iniae and V. harveyi (SVI) immunized by injection, S. iniae immunized by immersion (SIM), V. harveyi (VIM) immunized by immersion, bivalent S. iniae and V. harvei (SVIM) immunized by immersion, phosphate-buffered saline (PBS) by injection (PBSI) and control group without vaccine administration (CTRL). Blood and serum samples were taken at the end of the 30th and 60th days. Then the vaccinated groups were challenged with two bacteria (S. iniae) and (V. harveyi) separately and mortality was recorded for 14 days.

Results

This study reveals that there is no significant difference in the hematological parameters on the 30th and 60th days of the experiment in the vaccine-immunized groups compared to the CTRL group (P > 0.05). Meanwhile, there was no significant difference in the amount of serum albumin level, respiratory burst activity, and serum bactericidal activity in the vaccine-immunized groups compared to the CTRL group on the 30th and 60th days of the experiment (P > 0.05). Total protein on the 60th day (in the VI and SVI groups), globulin on the 30th day (in the VI and SVI groups) and the 60th day (in the VI group) compared to the CTRL and PBSI groups had a significant increase (P < 0.05). Complement activity (in the VI and SVI groups) and lysozyme (in the SI and SVI groups) increased significantly compared to the control group (P < 0.05). Serum antibody titer against S. iniae had a significant increase in the SI, VI, SVI and SVIM groups compared to the CTRL and PBSI groups (P < 0.05). Serum antibody titer against V. harveyi had a significant increase in the groups immunized with the vaccine compared to the CTRL and PBSI groups (P < 0.05). A significant increase in the relative percentage survival (RPS) following challenge with S. iniae in the SVI (86.6%), SI (83.3%,) and VI (73.3%) groups were observed compared to the CTRL (43.3%) and PBSI (40%) groups (P < 0.05). Also, a significant increase in the RPS after challenge with V. harveyi in the SVI group, VI 86.6%, SVI 83.3%, VIM 80% and SVIM 76.6% were observed compared to the CTRL (46.6%) and PBSI (50%) groups (P < 0.05).

Conclusion

Overall, the results demonstrated that the bivalent vaccine of S. iniae and V. harveywas able to produce significant immunogenicity and RPS in Asian seabass

Peer Review reports

Background

The significant increase in population and the demand for aquatic consumption besides the limitation of natural resources have led to the development of the aquaculture industry in the world [1]. Aquaculture has recently emerged as one of the most efficient methods for producing food and has quickly developed into an active and expanding industry [2]. The need for aquatic proteins has led to the change of extensive farming systems towards intensive and super-intensive farming [3]. Therefore, intensive and super-intensive fish farming increases the susceptibility of fish to infectious diseases, which has a serious negative impact on the economy [4]. The most serious pathogens in aquaculture are bacteria (54.9%), viruses (22.6%), parasites (19.4%) and fungi (3.1%), respectively [5]. The main issue in the aquaculture industry is bacterial infections [6]. Antibiotics are used as the first choice to control bacterial disease [7]. However, the uncontrolled use of antibiotics disrupts animal protein production, microbiota, nutrition and immunity which poses a great risk to human health [8]. Antibiotics can eliminate beneficial microorganisms and disrupt the microbiota of the gastrointestinal tract, affecting nutrition and immunity [9]. Antibiotic usage has the potential to select resistant bacteria and transfer resistance genes to animals and human microbiome [10]. Due to the mentioned problems, the use of antibiotics is no longer a priority and there is a serious need to find suitable environmental alternatives to solve problems related to antibiotics. Today, vaccines are the best way to prevent and control infectious diseases [11]. Unlike antibiotics, vaccines stimulate the fish’s immune system and protect the fish from pathogens [12]. In other words, the significant increase in requests and the intensive system in aquaculture lead to the intensification of stress and the occurrence of diseases in aquatic animals [13]. The two most prevalent bacterial infections in Asian seabass farming are Vibriosis and Streptococcosis, which can cause severe economic losses [14]. Asian seabass infected with Vibrio harveyi (V. harveyi) shows lethargy, anorexia, abnormal swimming, abdominal distension, ulcerative skin lesions and darkened skin [15]. Meanwhile, fish infected with Streptococcus iniae (S. iniae) shows clinical symptoms such as irregular swimming, loss of equilibrium, unilateral or bilateral exophthalmia, darkening of the skin, darkening of the cornea, and hemorrhaging in the fins [16].

Monovalent vaccinations are currently no longer cost-effective due to co-infection rises in agriculture. On the other hand, polyvalent vaccines are vital in the aquaculture vaccination process because of stress reduction, cost-effectiveness, and resistance to multiple infections [6].

Recently, the demand for purchasing Asian seabass has increased. This could be due to the good taste and increasing awareness about the beneficial properties of this fish, such as protein and omega-3 fatty acids, which are high in Asian seabass [17]. Asian seabass (Lates calcarifer) is a euryhaline carnivorous fish that has high economic value, fast growth and can be widely cultured in freshwater and marine waters [18]. Asian seabass is a protandrous hermaphrodite and fish that has wide physiological tolerances [19].

Previous research showed that polyvalent vaccines have a positive and significant effect on the immunogenicity and survival of fish. In a study, the effect of polyvalent vaccine against Streptococcosis, Vibriosis, and Aeromonas Septicemia in L. calcarifer was investigated and it was reported that the vaccine has a significant effect on the immunogenicity of Asian seabass [14]. Moreover, in another study, the effect of polyvalent yersiniosis, streptococcosis and lactococcosis, vaccine was investigated in Oncorhynchus mykiss and it was reported that this vaccine has significant immunogenicity in rainbow trout [6]. Considering the positive effects of vaccines in previous studies, in this study the effectiveness of bivalent and monovalent vaccines by immersion and injection method on immune response and disease resistance against Streptococcus and Vibriosis in L. calcarifer were investigated.

Results

Hematological parameters

On the 30th day and the 60th day of sampling, there was no significant difference in blood parameters such as RBCs, WBCs, Hb, % Hct, Lym, Neut and other leukocytes in different groups (Figs. 1, 2, 3, 4, 5, 6 and 7, P > 0.05). Also, the main effect of time was not significant in all groups in the hematological factors (Figs. 1, 2, 3, 4, 5, 6 and 7, P > 0.05). The interaction between time and treatment RBC (P > 0.9909), WBC (P > 0.9967), Hb (P > 0.9199), %Hct (P > 0.9998), Lym (P > 0.9008), Neut (P > 0.8478) and other leukocytes (P > 0.9535) were not significant in any of the hematological parameters.

Fig. 1
figure 1

RBCs count in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups were not significant (P > 0.05). Interaction of time × treatment: P = 0.9909. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. RBC: red blood cell, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 2
figure 2

WBCs count in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.9967. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. WBC: white blood cell, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 3
figure 3

Hb concentration in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.9199. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. Hb: hemoglobin, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 4
figure 4

The percentage of Hct in the groups vaccinated with V. harveyi and S. iniae in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.9998. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. Hct: hematocrit, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 5
figure 5

The percentage of Lymphocytes in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.9008. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. Lym: lymphocytes, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 6
figure 6

The percentage of Neutrophils in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.8478. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. Neut: neutrophils, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 7
figure 7

The other leukocytes in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.9535. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image

Serum biochemical parameters

On the 30th day, there was no significant difference in the amount of Tp in all groups compared to the CTRL group, but on the 60th day, there was a significant difference in the amount of Tp in VI and SVI compared to the CTRL and PBSI groups (Fig. 8, P < 0.05). The main effect of time in all groups (except the VI group) was not significant in the activity of serum Tp (Fig. 8, P > 0.05), but the interaction between treatment and time was significant in the activity of serum Tp (P < 0.0288). On the 30th and 60th days, there was no significant difference in serum Alb activity in all groups compared to the CTRL group (Fig. 9, P > 0.05). The main effect of time in all groups (Fig. 10, P > 0.05), as well as the interaction between treatment and time, had no significant difference in activity of serum Alb (P > 0.9711). The activity of serum Glb on the 30th day (VI and SVI groups compared to the CTRL group and SVI compared to the PBSI group) and the 60th day (VI group compared to the CTRL and PBSI groups) had a significant increase (Fig. 10, P < 0.05). The main effect of time in all groups (Fig. 9, P > 0.05) and the interaction between treatment and time in serum Glb activity were not significant (P > 0.0508).

Fig. 8
figure 8

The activity of serum Total protein in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (except VI group), (P > 0.05). Interaction of time × treatment: P = 0.0442. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 9
figure 9

The activity of serum Albumin in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.9711. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 10
figure 10

The activity of serum Globulin in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.0508. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image

Non-specific immune parameters

No significant difference was observed in the activity of serum NBT on the 30th and 60th days of sampling in all groups compared to the CTRL group (Fig. 11, P > 0.05). The main impact of time in all groups (Fig. 11, P > 0.05), as well as the interaction between treatment and time, had no significant difference in serum NBT (P > 0.9999). The activity of serum lysozyme was significantly increased on the 30th day (SI group compared to the CTRL and PBSI group), (Fig. 12, P < 0.05) and on the 60th day of sampling (SVI group compared to the CTRL group), (Fig. 12, P < 0.05). The main impact of time in all groups (except PBSI) was not significant in the activity of serum lysozyme (Fig. 12, P > 0.05). The interaction between treatment and time was significant in the activity of serum lysozyme (P < 0.0025). On the 30th day of sampling, no significant difference was observed in the amount of serum complement in all groups compared to the CTRL group (Fig. 13, P > 0.05), but on the 60th day of sampling, a significant increase in serum complement levels was observed in the VI and SVI groups compared to the CTRL and PBSI groups (Fig. 13, P < 0.05). The main impact of time was not significant in all groups compared to the CTRL group in activity of serum complement (Fig. 13, P > 0.05). Also, no significant difference was observed in the interaction between treatment and time in activity of serum complement (P > 0.6217).

Fig. 11
figure 11

The activity of serum NBT in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P > 0.9999. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. NBT: nitroblue tetrazolium, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 12
figure 12

The activity of serum lysozyme in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.0025. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 13
figure 13

The activity of serum complement components in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.6217. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image

Serum bactericidal activity

The bactericidal activity of serum against V. harveyi on the 30th and 60th days of sampling in all groups was not significant compared to the CTRL group (Fig. 14, P > 0.05). The main impact of time (Fig. 14, P > 0.05), and the interaction of time in the treatment were not significant in the bactericidal activity of serum against V. harveyi (P > 0.7128).

Fig. 14
figure 14

Serum bactericidal activity against V. harveyi in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.7128. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image

Antibody titer

The serum antibody titer against S. iniae on the 30th and 60th days of sampling had a significant difference in the SI, VI, SVI and SVIM groups compared to the CTRL and PBSI groups (Fig. 15, P < 0.05). The main effect of time on the serum antibody titer against S. iniae in all groups was not significant on day 30 compared to day 60 (Fig. 15, P > 0.05). Also, the serum antibody titer against S. iniae was not significant in the interaction between treatment and time (P = 0.4945). The serum antibody titer against V. harveyi on the 30th day (in the SI, VI, SVI, VIM and SVIM groups) and on the 60th day (in the SI, VI, SVI and SVIM groups) had a significant increase compared to the CTRL and PBSI groups (Fig. 16, P < 0.05). The main effect of time in serum antibody titer against V. harveyi was not significant in all groups on day 30 compared to day 60 (Fig. 16, P < 0.05), but serum antibody titer against V. harveyi was significant in the interaction between treatment and time (P = 0.0186).

Fig. 15
figure 15

Antibody titer against S. iniae in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.4945. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion. *: P = 0.0164, **: P = 0.0060, ***: P = 0.0002. ****: P < 0.0001

Full size image
Fig. 16
figure 16

Antiboby titer against V. harveyi in the groups vaccinated with S. iniae and V. harveyi in Asian seabass. The effect of time in all groups was not significant (P > 0.05). Interaction of time × treatment: P = 0.0186. Values are Mean ± SD (n = 9 fish per treatment). Statistical significance was measured using Tukey’s test and two-way ANOVA to show the difference groups over time. CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion. *: P = 0.0263, **: P = 0.0047, ****: P < 0.0001

Full size image

Survival post-challenge

After 14 days of challenge with S. iniae bacteria, SI (P = 0.0013), VI (P = 0.0178) and SVI (P = 0.0004) groups had a significant increase in relative percentage survival (RPS) compared to the CTRL and PBSI groups (Fig. 17). The SVI group with 86.6% highest survival rate and PBSI group with 40% lowest survival rate (SR) are shown in Fig. 17. Also, after 14 days of challenge with V. harveyi, VI (P = 0.0015), SVI (P = 0.0025), VIM (P = 0.0096) and SVIM (P = 0.0187) groups had a significant increase in RPS compared to the CTRL and PBSI groups (Fig. 18). The VI group with 86.6% highest SR and CTRL group with 46.6% lowest SR are shown in Fig. 18.

Fig. 17
figure 17

Cumulative survival rate of Asian seabass after 14 days of challenge with S. iniae (Kaplan-Meier curve). Values are Mean ± SD (n = 30 fish per treatment). Statistical significance was measured using Tukey’s test and one-way ANOVA to show the different groups over time. S. iniae: Streptococcus iniae, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image
Fig. 18
figure 18

Cumulative survival rate of Asian seabass after 14 days of challenge with V. harveyi (Kaplan-Meier curve). Values are Mean ± SD (n = 30 fish per treatment). Statistical significance was measured using Tukey’s test and one-way ANOVA to show the different groups over time. V. harveyi: Vibrio harveyi, CTRL: control, PBSI: Phosphate-buffered saline injection, SI: S. iniae injection, VI: V. harveyi injection, SVI: S. iniae and V. harveyi injection, SIM: S. iniae immersion, VIM: V. harveyi immersion, SVIM: S. iniae and V. harveyi immersion

Full size image

Discussion

Many vaccines have been developed recently to protect fish in aquaculture from acute bacterial infections such as Vibriosis [14], Streptococcosis [20], Edwardsiellosis [21], Yersiniosis [6] and Furunculosis [22]. The bivalent and polyvalent vaccines are safe for fish and consumers, have long-term immunity, easy to use, cost-effective, and are applicable for co-infections [6, 14]. Therefore, in the present study, we used a bivalent formalin-inactivated vaccine to protect against Streptococcosis and Vibriosis by injection and immersion methods, which might cover all the requirements of a potential vaccine. Our study showed that the bivalent vaccine does not have a significant effect on blood parameters on the 30th and 60th day. The blood parameters are considered as a vital indicator of health status in aquatic animals. In line with our results, the effect of Aeromonas salmonicida vaccine in pikeperch (Sander lucioperca) was investigated in a study [23]. The results showed that this vaccine had no significant effect on blood parameters such as WBC, RBC, %HCT, MCH and MCHC [23]. In another study, the effect of two different adjuvants on Streptococcus agalactiae vaccine was investigated in Nile tilapia. The results showed that this vaccine has no significant effect on blood parameters such as %HCT, MCV, MCHC, MCH and total erythrocytes [24].

Serum biochemical parameters such as Tp, Alb and Glb are considered as one of the effective indicators of humoral immunity, pathological and welfare status of fish [25]. In the present study, it has been shown that Tp in the vaccinated groups (VI and SVI on the 60th day) and Glb (in the VI and SVI groups on the 30th day and VI on the 60th day) were significant increase compared to the control group. Consistent with our results, the increase of mucosal immune response in Labeo rohita was investigated using recombinant bicistronic nano DNA vaccine priming against Edwarsiella tarda. The results showed that the recombinant bicistronic nano DNA vaccine priming against E. tarda has a significant difference in blood biochemical factors such as Tp, Alb and Glb of blood serum [26]. In another study, the effect of Streptococcosis vaccine in Nile tilapia had a significant increase in Glb and Tp, but did not affect Alb [24]. Globulin is necessary to regulate and increase the efficiency of the fish’s immune system, and an increase in the amount of globulin indicates a strong innate immune system [27].

One of the important defense mechanisms against pathogenic bacteria is phagocytic activity by phagocytic cells. During the respiratory burst activity, phagocytic cells can produce superoxide anions, which are toxic forms of oxygen and lead to the elimination of bacteria [28]. In this study, vaccinated fish did not show any significant difference in blood NBT levels. Contrary to our results, the increase in blood NBT levels in the inactivated vaccine encapsulated with nano-chitosan against A. hydrophila in rainbow trout (Oncorhynchus mykiss) [29], oral polylactic-co-glycolic acid nano-encapsulated DNA vaccine against A. hydrophila in common carp [30] and Vibriosis vaccine in turbot Scophthalmus maximus [31] have been reported. The NBT index is one of the non-specific immune response indices to evaluate the level of phagocytosis. In the final stage of phagocytosis or intracellular killing, the creation of respiratory burst activity, which is under the influence of free radicals produced in phagocytic cells, is performed by nitrobutrazolium. Since vaccination with killed bacteria has the greatest effect on humoral immunity. It is possible that some non-specific immunity indicators are significantly affected by vaccination. On the other hand, many other environmental and physiological factors have an effect on the amount of phagocytosis (apart from the prescribed vaccine) and the increase in NBT activity is actually one of the factors affecting phagocytosis, which in the current research, despite a mild increase, was not statistically significant.

The complement system can cause activation, phagocytosis, chemotaxis, inflammatory response, opsonization and immunocytes for pathogens and plays a major role in the innate immunity of fish [32]. In the present study, serum complement activity on the 60th day of sampling was significantly increased in the VI and SVI vaccinated groups compared to the CTRL and PBSI groups. Consistent with our results, the V. mimicus vaccine in Carassius auratus [33], polyvalent streptococcosis/yersiniosis vaccine in rainbow trout [6] and bivalent V. scophthalmi and A. salmonicida vaccines in turbot (S. maximus) [34] had a positive and significant effect on the complement system of fish. The increase of complement activity after immunization with both monovalent and bivalent vaccines, proved the effectiveness of inactivated vaccines against S. iniae and V. harveyi in Asian seabass.

Non-specific immune response is the first defense line in fish, which plays an important role in the secondary or specific immune system and the regulation of body homeostasis [35]. Due to its close relationship with leukocytes, lysozyme is an accepted and preferred marker of immune response, which is produced by macrophages and many other immune stimuli in response to pathogenic components [36]. In the current study, serum lysozyme activity increased significantly on day 30 (SI group compared to CTRL and PBSI group) and on day 60 of sampling (SVI group compared to CTRL group). In line with our results, in a study, the effect of V. harveyi vaccine combined with chitosan and astragalus polysaccharide in ♀Epinephelus fuscoguttatus × ♂Epinephelus lanceolatus had a significant effect on lysozyme activity compared to the control group [37]. Several studies prove the effect of polyvalent vaccine on increasing lysozyme activity, for example, the combination of V. anguillarum and Edwardsiella piscicida vaccine in turbot [38], the polyvalent yersiniosis and streptococcosis/lactococcosis vaccine in O. mykiss [6] and the bivalent A. salmonicida and E. tarda vaccine in turbot [39]. Considering the bactericidal properties of lysozyme and the increased activity of serum lysozyme in the groups immunized with the vaccine compared to the control group, it probably indicates the greater function of the non-specific immune system of fish against pathogenic agents.

Serum antibody titer is one of the most vital indicators to evaluate the immunogenicity of vaccines [38]. The comparison of serum antibody titers against S. iniae (in the SI, VI, SVI and SVIM groups) and V. harveyi (in the SI, VI, SVI, VIM and SVIM groups) in the vaccinated groups was significant compared to the control group. In line with our results, the bivalent A. salmonicida and V. anguillarum vaccine in Atlantic salmon [40], the polyvalent yersiniosis and streptococcosis/lactococcosis vaccine in O. mykiss [6], the bivalent vibriosis and edwardsillosis vaccine in turbot [38], the bivalent vibriosis vaccine in turbot [41], the bivalent vibriosis in gilthead sea bream [42] and the bivalent V. scophthalmi and A. salmonicida vaccine in turbot [34], support our findings. The reason for the increase in the levels of antibodies may be due to the specific production by the host. Meanwhile, the cell membrane of pathogenic organisms is in direct contact with the host’s immune system, and it has been proven that the membrane molecules of different types of microorganisms can stimulate strong cellular and humoral immune responses in fish. Effective mechanisms in the production of specific antibodies against proteins may include eliminating the ability of bacteria to stick and attack the host tissue, opsonizing bacterial cells and stimulating phagocytosis by macrophages and activating the complement cascade [43].

By evaluating the RPS, it is possible to check the resistance of the fish against the disease and the immunogenicity of the vaccine [41]. The RPS after exposure to S. iniae (SI, VI and SVI) and V. harveyi (VI, SVI, VIM and SVIM) had a significant increase compared to the control group. Several reports are showing that vaccination has increased RPS in fish (6, 14, 49). Similar to our findings, the RPS in the groups affected by polyvalent bacteria (V. parahaemolyticus and V. alginolyticus) and (V. parahaemolyticus and V. alginolyticus) were reported as 91.75% and 75%, respectively [42]. In another study, 80% (S. iniae), 90% (L. garvieae) and 80% (Y. ruckeri) RPS in the group immunized with injection vaccine and 50% (S. iniae), 70% (L. garvieae) and 60% (Y. ruckeri) were observed in the group immunized with immersion vaccine compared to the control group [6]. Also, in Asian seabass compared to the control group in line with our results, RPS after challenge with V. harveyi, A. hydrophila, and S. agalactiae was reported as 75%, 80%, and 80%, respectively (14). In another study, the percentage of relative survival after 14 days of challenge with S. iniae (70%), L. garviae (60%) and Y. ruckeri (76.6%) in the group immunized with injectable vaccine was significant compared to the control group (P < 0.05) [44].

Conclusion

Immunization using bivalent and polyvalent vaccines is one of the most ideal ways to deal with diseases, increase stimulation of the immune system response and reduce the cost of vaccination in farmed fish. Additionally, immunization of fish with inactivated vaccines via injection method, is a good and effective strategy to control many aquaculture diseases, since it provides a strong immune response, reduces infection rate, and increases survival rate. In general, the results showed that the bivalent formalin inactivated (S. iniae and V. harveyi ) vaccines had a significant increase in immunological parameters, antibody titer and RPS. Meanwhile, vaccination using bivalent vaccines by injection method has better immunogenicity than monovalent immersion and injection vaccines.

Materials and methods

Vaccine preparation

For this research, a pathogenic S. iniae (9609NB) and V. harveyi (SB9612N4) bacterial strains that were previously isolated from diseased Asian seabass cage cultures in Bushehr province (north of Persian Gulf, Iran) were used. These pathogenic strains, S. iniae in blood agar and V. harveyi in thiosulphate-citrate-bile-salts-sucrose (TCBS) agar, were cultured and maintained (30 ˚C for 48 h). Then bacterial strains were transferred to tryptone soy broth (TSB) medium (with the addition of NaCl 1.5% w/v for V. harveyi and S. iniae) at 30 ˚C for 48 h. Bacterial suspensions (S. iniae and V. harveyi) were mixed with 1% formalin and kept at 4 °C for 24 h. Afterward, the formalin inactivated bacterial mixture were centrifuged at 6000 × g for 10 min at 4 °C, the supernatant were discarded and the bacterial pellets were washed three times with sterile PBS. (To remove the remaining formalin). The bacterial pellets resuspended after washing in equal volumes of PBS to 1010 CFU/mL. The concentration of V. harveyi and S. iniae was adjusted to 1010 CFU/mL bacteria. Finally, the formalin killed bacterial suspensions (bacterin) were kept at 4 °C until use [42].

In-vivo experimental design

Asian seabass (L. calcarifer), (1200 pieces, 132.6 ± 25.4 g) was purchased from Bushehr, Iran and stored in breeding tanks. The fish were kept for two weeks to adapt before the investigation. Then, the fish were randomly divided into eight treatments in triplicate (500-liter tanks, 50 fish in each tank). Bivalent inactivated (S. iniae and V. harveyi) and monovalent inactivated (S. iniae and V. harveyi) vaccines were used for Asian seabass vaccination after stopping feeding for two days. The treatments are described in Table 1. The commercial feed (21 Beyza Mill Co., Shiraz, Iran) containing 46% crude protein, 16% crude fat, 3% fiber, 12% ash, 10% moisture and 4300 kcal/kg of digestible energy was used as the basic ration. The fish were hand-fed to apparent satiation twice a day. The physico-chemical factors of water such as dissolved oxygen (6.93 ± 0.25 mg/L− 1), water temperature (30 ± 1 °C), salinity (28 ppt) and photoperiod (12 h light: 12 h dark) were maintained during the acclimation and experimental period.

Table 1 Experimental design
Full size table

Vaccine administration

Monovalent and bivalent inactivated (S. iniae and V. harveyi) vaccines were used respectively to immunize fish. For immersion method, fish were immunized (SIM, VIM, and SVIM) in 109 CFU/mL vaccine (1:10 dilution of vaccine stock) for two minutes with adequate aeration. Following the same order of the experimental groups in Table 1, for the injection method, after anesthetizing the fish with clove powder (75 mg/L− 1), 0.1 mL of vaccine was injected intraperitoneally (IP) into the fish (SI, VI, and SVI). The PBSI group was injected with 0.1 mL of PBS instead of the vaccine.

Sampling procedure and measurement of hematological parameters

On the 30th day and 60th day after vaccination, the fish were stopped feeding for 24 h [42, 49]. Then the fish were anesthetized with clove powder (75 mg/L− 1), and blood samples were taken from the caudal vein (9 fish from each treatment). Blood samples (2 mL) were divided for serum separation (without anti-coagulant) and for measuring hematological parameters (containing heparin anti-coagulant). The blood samples without anti-coagulant were centrifuged at 3500 rpm for 10 min at room temperature (RT). Then supernatants (serum) were kept at − 80 °C for further analysis. Following the methodology described by Grant for measuring blood parameters [45]. In each stage of sampling, 9 fish were sampled from each treatment.

Serum biochemical parameters

Biochemical parameters of blood serum such as total protein (Tp) and albumin (Alb) were determined using a commercial kit (Pars Azmoon, Tehran, Iran) based on the methodology of Hoseinifar et al. [46]. The level of serum globulin (Glb) was estimated by subtracting the amount of Alb from the amount of Tp [46].

Measurement of non-specific immune parameters

Respiratory burst activity was done using Yonar method with some modification [47]. To measure the respiratory burst activity of WBCs, 0.1 mL of heparinized blood was mixed with 0.1 mL of 0.2% nitro blue tetrazolium (NBT) solution and incubated for 30 min at 25 °C. Then 0.1 mL of the mixture was added to 1 ml of dimethylformamide solution. After centrifuging the samples, the supernatant was measured at a wavelength (WL) of 540 nm [47]. The serum lysozyme activity was measured by enzyme-linked immunosorbent assay (ELISA) method. Hence, 9 mg of Micrococcus luteus bacterial wall was dissolved in 30 ml of sodium phosphate buffer (pH = 6.2). Then, 10 µL of serum sample was mixed with 90 µl of bacterial wall suspension. The samples were recorded with a WL of 450 nm for 10 min. Each 0.001 unit of decrease in absorbance per minute was considered equivalent to one active unit of lysozyme [48]. To measure complement activity, inactive serum of rabbits immunized with sheep RBCs at a concentration of 25% with 10% sheep RBCs was stored for 24 h at 4 °C and washed with PBS and the supernatant was discarded. Then, 25 µL of active sera plus 375 µL of complement buffer and 100 µL of 5% washed sheep red blood cells were mixed and placed in a 37 °C incubator for 45 min. The mixed solution was centrifuged for 5 min at 3,000 g per minute and 100 µL of the supernatant of each serum was collected and poured into a 96-well ELISA plate, and finally, the optical density (OD) of the samples was measured at a WL of 490 nm [49].

Bactericidal activity

To measure the bactericidal activity of serum, the method described by Budino et al. [50] was used with some modifications. Briefly, after V. harveyi (2 × 107 CFU/mL) was added to the serum samples, they were incubated for 6 h at 20 °C and then MTT (dimethylthiazole-diphenyltetrazolium bromide) was added to the suspension. After 15 min of incubation at RT, the samples were measured by the color change caused by the reduction of MTT by living bacteria at a WL of 630 nm by an ELISA reader.

Antibody titer

Serum antibody titer against S. iniae and V. harveyi was measured by the method recommended by Skov et al. [51] with slight modifications by the ELISA reader. Briefly, 50 µL of soluble antigens [S. iniae and V. harveyi (100 g/mL− 1)] in bicarbonate buffer (pH = 9.6) were added to each well of the ELISA plates and incubated overnight at 4 °C. The samples of each well were washed three times with 1% PBS containing Tween-20 (PBS-T). Then, they were blocked with 2.5% skim milk in PBS-T for 3 h at 37 °C. After 3 washes with buffer, the serum samples were diluted 1:400 in PBS-T and 1% skim milk and 100 µL of the suspension was added to the wells. The plate was placed on a shaker for 90 min at RT and after washing 4 times, the rabbit’s anti-seabass polyclonal antibody was diluted 1:20. 100 µL of the suspension was added to the wells and incubated for one hour at RT. After washing, 50 µL of goat anti-rabbit IgG HRP conjugate with a dilution of 1:3000 was added to the wells. Finally, 50 µL of chromogenic substrate solution was added to the wells and after 10 min of incubation at RT, 50 µL of stopping solution (2% sulfuric acid) was added to the wells. The OD of the samples was determined by an ELISA reader at a WL of 490 nm.

Determination of lethal dose (LD50)

To determine the LD50, 10-fold serial dilutions (105-108 CFU mL− 1) using PBS were prepared for S. iniae and V. harveyi. 0.1 mL of each bacterial dilution was injected IP into 10 fish per each bacterial strain, separately. After IP injection, mortality was recorded for 10 days and then the LD50 was determined with Probit software.

Challenge experiment

To determine the percentage of survival rate (SR) after 60 days of vaccination, 30 fish from the group (10 fish from each replication) were challenged IP and observed for 14 days. All fish groups were challenged against each individual bacterium (S. iniae and V. harveyi) to detect the cross-protection level. Prior to injection, fish were anesthetized with clove powder (75 mg/L− 1), then injected with 0.1 mL of each bacterial suspension (LD50 = 4.9 × 106 CFU mL− 1 of S. iniae and LD50 = 6.8 × 107 CFU mL− 1 of V. harveyi); separately were injected IP to the fish. The cumulative mortality of fish was recorded for 14 days and the relative percentage of survival (RPS) of fish was calculated through the following formula [14].

$${\rm{RPS = 1 - }}\left( {{\rm{mortality}}\,\,{\rm{in}}\,\,{\rm{vaccinates}}\,{\rm{/}}\,{\rm{mortality}}\,{\rm{in}}\,{\rm{controls}}} \right){\rm{ \times 100}}$$

After the bacterial challenge, and at the end of the experiment, the fish were treated and healthy fish returned to rearing conditions.

Statistical analysis

The GraphPad PRISM software (version 9.5.1.733) was used for statistical data analysis. First, the homogeneity and normality of the data were checked using the Kolmogorov-Smirnov statistical test. Then, two-way analysis of variance (Two-way ANOVA) and Tukey’s analysis of variance were performed to compare vaccinated and non-vaccinated groups over time. One-way analysis of variance (One-way ANOVA) and Tukey’s test were used to analyze survival rate data using GraphPad Prism software. Data are presented as mean ± SD. Significance level was set at P < 0.05.

Accession numbers

S. iniae (accession number 9609NB) and V. harveyi (accession number SB9612N4).

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

S. iniae :

Streptococcus iniae

V. harveyi :

Vibrio harveyi

SI:

Streptococcus iniae injection

VI:

Vibrio harveyi injection

SVI:

bivalent S. iniae and V. harvey injection

SIM:

Streptococcus iniae immersion

VIM:

Vibrio harveyi immersion

SVIM:

bivalent S. iniae and V. harvey immersion

CTRL:

Control

Tp:

total protein

Alb:

albumin

Glb:

globulin

RPS:

relative percentage of survival

PTCC:

Persian type culture collection

SD:

standard deviation

LD:

lethal dose

ANOVA:

analysis of variance

SR:

survival rate

RT:

room temperature

OD:

optical density

ELISA:

enzyme-linked immunosorbent assay

References

  1. Azra MN, Okomoda VT, Tabatabaei M, Hassan M, Ikhwanuddin M. The contributions of shellfish aquaculture to global food security: assessing its characteristics from a future food perspective. Front Mar Sci. 2021;8:654897.

    Article  Google Scholar 

  2. D’Agaro E, Gibertoni P, Esposito S. Recent trends and economic aspects in the rainbow trout (Oncorhynchus mykiss) sector. Appl Sci. 2022;12:8773.

    Article  Google Scholar 

  3. Kumareswaran K, Jayasinghe GY. Systematic review on ensuring the global food security and covid-19 pandemic resilient food systems: towards accomplishing sustainable development goals targets. Discov Sustain. 2022;3:29.

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  4. Dawood MAO, El Basuini MF, Zaineldin AI, Yilmaz S, Hasan MT, Ahmadifar E, et al. Antiparasitic and antibacterial functionality of essential oils: an alternative approach for sustainable aquaculture. Pathogens. 2021;10:185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Natnan ME, Mayalvanan Y, Jazamuddin FM, Aizat WM, Low CF, Goh HH, et al. Omics strategies in current advancements of infectious fish disease management. Biology (Basel). 2021;10:1086.

    CAS  PubMed  Google Scholar 

  6. Erfanmanesh A, Beikzadeh B, Khanzadeh M. Efficacy of polyvalent vaccine on immune response and disease resistance against streptococcosis/lactococcosis and yersiniosis in rainbow trout (Oncorhynchus mykiss). Vet Res Commun. 2023; 1–9.

  7. Samtiya M, Matthews KR, Dhewa T, Puniya AK. Antimicrobial resistance in the food chain: Trends, mechanisms, pathways, and possible regulation strategies. Foods. 2022;11:2966.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Treiber FM, Beranek-Knauer H. Antimicrobial residues in food from animal origin—A review of the literature focusing on products collected in stores and markets worldwide. Antibiotics. 2021;10:534.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Shah T, Baloch Z, Shah Z, Cui X, Xia X. The intestinal microbiota: impacts of antibiotics therapy, colonization resistance, and diseases. Int J Mol Sci. 2021;22:6597.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kunhikannan S, Thomas CJ, Franks AE, Mahadevaiah S, Kumar S, Petrovski S. Environmental hotspots for antibiotic resistance genes. Microbiologyopen. 2021;10:1197.

    Article  Google Scholar 

  11. Costanzo V, Roviello GN. The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives, Vaccines. 2023; 11, 333.

  12. Wang B, Thompson KD, Wangkahart E, Yamkasem J, Bondad-Reantaso MG, Tattiyapong P, et al. Strategies to enhance tilapia immunity to improve their health in aquaculture. Rev Aquac. 2023;15:41–56.

    Article  CAS  Google Scholar 

  13. Khanzadeh M, Beikzadeh B, Hoseinifar SH. The Effects of Laurencia caspica Algae Extract on Hemato-Immunological Parameters, Antioxidant Defense, and Resistance against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus), Aquac Nutr. 2023; 2023.

  14. Mohamad A, Zamri-Saad M, Amal MNA, Al-Saari N, Monir MS, Chin YK, et al. Vaccine efficacy of a newly developed feed-based whole-cell polyvalent vaccine against vibriosis, streptococcosis and motile aeromonad septicemia in Asian Seabass, Lates calcarifer. Vaccines. 2021;9:368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cámara-Ruiz M, Cerezo IM, Guardiola FA, García-Beltrán JM, Balebona MC, Moriñigo MÁ et al. Alteration of the Immune Response and the Microbiota of the Skin during a Natural Infection by Vibrio harveyi in European Seabass (Dicentrarchus labrax), Microorganisms. 2021; 9, 964.

  16. Tanpichai P, Chaweepack S, Senapin S, Piamsomboon P, Wongtavatchai J. Immune Activation following vaccination of Streptococcus iniae Bacterin in Asian Seabass (Lates calcarifer, Bloch 1790). Vaccines. 2023;11:351.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Nhan DT, Tu NPC, Van TN. Comparison of growth performance, survival rate and economic efficiency of Asian seabass (Lates calcarifer) intensively cultured in earthen ponds with high densities. Aquaculture. 2022;554:738151.

    Article  CAS  Google Scholar 

  18. Bunnoy A, Thangsunan P, Chokmangmeepisarn P, Yata T, Klongklaew N, Pirarat N, et al. Mucoadhesive cationic lipid-based Flavobacterium Oreochromis nanoencapsulation enhanced the efficacy of mucoadhesive immersion vaccination against columnaris disease and strengthened immunity in Asian sea bass (Lates calcarifer). Fish Shellfish Immunol. 2022;127:633–46.

    Article  CAS  PubMed  Google Scholar 

  19. Hassan HU, Ali QM, Ahmad N, Masood Z, Hossain MY, Gabol K, et al. Assessment of growth characteristics, the survival rate and body composition of Asian Sea bass lates calcarifer (Bloch, 1790) under different feeding rates in closed aquaculture system. Saudi J Biol Sci. 2021;28:1324–30.

    Article  Google Scholar 

  20. Akter T, Ehsan R, Paul SI, Ador MAA, Rahman A, Haque MN, et al. Development of formalin killed vaccine candidate against streptococcosis caused by Enterococcus sp. in Nile tilapia. Aquac Rep. 2022;27:101371.

    Article  Google Scholar 

  21. Swain B, Campodonico VA, Curtiss R III. Recombinant attenuated Edwardsiella piscicida vaccine displaying regulated lysis to Confer Biological Containment and protect catfish against Edwardsiellosis. Vaccines. 2023;11:1470.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lim J, Hong S. Transcriptome Analysis in the Head kidney of Rainbow Trout (Oncorhynchus mykiss) immunized with a combined vaccine of Formalin-Inactivated Aeromonas salmonicida and Vibrio anguillarum. Vaccines. 2021;9:1234.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Schulz P, Terech-Majewska E, Siwicki AK, Kazuń B, Demska-Zakęś K, Rożyński M, et al. Effect of different routes of vaccination against Aeromonas salmonicida on rearing indicators and survival after an experimental challenge of Pikeperch (Sander lucioperca) in controlled rearing. Vaccines. 2020;8:476.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ramos-Espinoza FC, Cueva-Quiroz VA, Yunis-Aguinaga J, Alvarez-Rubio NC, de Mello NP, de Moraes JRE. Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings. Fish Shellfish Immunol. 2020;105:350–8.

    Article  CAS  PubMed  Google Scholar 

  25. Ismael NEM, Abd El-hameed SAA, Salama AM, Naiel MAE, Abdel-Latif HMR. The effects of dietary clinoptilolite and chitosan nanoparticles on growth, body composition, haemato-biochemical parameters, immune responses, and antioxidative status of Nile tilapia exposed to imidacloprid. Environ Sci Pollut Res. 2021;28:29535–50.

    Article  CAS  Google Scholar 

  26. Leya T, Ahmad I, Valappil RK, Kurcheti PP, Tripathi G, Sharma R, et al. Development of species-specific IgM antibodies and elevation of mucosal immune response in Labeo rohita using recombinant bicistronic nano DNA vaccine priming. Fish Shellfish Immunol. 2021;113:185–95.

    Article  CAS  PubMed  Google Scholar 

  27. Zhang Y, Liang XF, He S, Feng H, Li L. Dietary supplementation of exogenous probiotics affects growth performance and gut health by regulating gut microbiota in Chinese perch (Siniperca chuatsi). Aquaculture. 2022;547:737405.

    Article  CAS  Google Scholar 

  28. Sibiya A, Al-Ghanim KA, Govindarajan M, Nicoletti M, Sachivkina N, Vaseeharan B. Biochemical Patterns and Genotoxicity of the Endocrine Disruptor Metformin in the Freshwater Fish Labeo rohita, Fishes. 2023; 8, 380.

  29. Dehghan P, Shabanipour N, Zamani H. Immunogenic potential of inactivated Aeromonas hydrophila encapsulated in nanochitosane/sodium alginate microspheres for oral vaccination of rainbow trout (Oncorhynchus mykiss). Aquac Res. 2022;53:1507–17.

    Article  CAS  Google Scholar 

  30. Alishahi M, Vaseghi M, Tabandeh MR, Khosravi M. Immunogenic and protective effects of an oral polylactic-co-glycolic acid nano encapsulated DNA vaccine encoding aopB gene of Aeromonas hydrophila in common carp. Aquac Int. 2023; 1–22.

  31. Gu Qqin, Wang Ghua, Li Nqiu, Hao D, Liu Hmei, Wang C et al. Evaluation of the efficacy of a novel Vibrio vulnificus vaccine based on antibacterial peptide inactivation in turbot, Scophthalmus maximus, Fish Shellfish Immunol. 2021; 118, 197–204.

  32. Li Mfei, Zhang Hqiang, Sun J. A novel C1qDC (PoC1qDC) with a collagen domain in Paralichthys olivaceus mediates complement activation and against bacterial infection, Fish Shellfish Immunol. 2023; 132, 108472.

  33. Yang BT, Zhao T, Li HJ, Liang ZL, Cong W, Kang YH. Lc-pPG-612-OmpU-CTB: a promising oral vaccine for protecting Carassius auratus against Vibrio mimicus infection. Fish Shellfish Immunol. 2023;140:108973.

    Article  CAS  PubMed  Google Scholar 

  34. Zhou S, Zheng X, Ding Y, Su L, Huang Q, Xiu Y. Immuno-Protective efficiency of the Bivalent Inactivated Vaccine against Vibrio scophthalmi and Aeromonas salmonicida infections in Turbot (Scophthalmus maximus L). J Ocean Univ China. 2023;22:1079–86.

    Article  CAS  Google Scholar 

  35. Bae J, Lee S, Moniruzzaman M, Hamidoghli A, Choi W, Lee S, et al. Evaluation of dietary fish meal analog with or without supplementation of natural feed additives as the substitute of fish meal in juvenile Japanese eel, Anguilla japonica. Front Mar Sci. 2022;9:931940.

    Article  Google Scholar 

  36. Harikrishnan R, Devi G, Van Doan H, Vijay S, Balasundaram C, Ringø E, et al. Dietary plant pigment on blood-digestive physiology, antioxidant-immune response, and inflammatory gene transcriptional regulation in spotted snakehead (Channa punctata) infected with Pseudomonas aeruginosa. Fish Shellfish Immunol. 2022;120:716–36.

    Article  CAS  PubMed  Google Scholar 

  37. Wei G, Cai S, Wu Y, Ma S, Huang Y. Immune effect of Vibrio harveyi formalin-killed cells vaccine combined with chitosan oligosaccharide and astragalus polysaccharides in♀ Epinephelus fuscoguttatus×♂ Epinephelus lanceolatus. Fish Shellfish Immunol. 2020;98:186–92.

    Article  CAS  PubMed  Google Scholar 

  38. Bao P, Sun X, Liu Q, Zhang Y, Liu X. Synergistic effect of a combined live Vibrio anguillarum and Edwardsiella Piscicida vaccine in turbot. Fish Shellfish Immunol. 2019;88:84–90.

    Article  CAS  PubMed  Google Scholar 

  39. Su L, Guo H, Guo B, Yi J, Yang Z, Zhou S et al. Efficacy of bivalent vaccine against Aeromonas salmonicida and Edwardsiella tarda infections in turbot. Fish Shellfish Immunol. 2023; 108837.

  40. Kuang B, Xiao K, Wang W, You F, Xiao P, Chen S. Different antigen ratio in bivalent vaccine can affect immunological activation and protection against Aeromonas salmonicida and Vibrio anguillarum in Atlantic salmon. Fish Shellfish Immunol. 2022;128:644–50.

    Article  CAS  PubMed  Google Scholar 

  41. Zhang J, Hu Y, Sun Q, Li X, Sun L. An inactivated bivalent vaccine effectively protects turbot (Scophthalmus maximus) against Vibrio anguillarum and Vibrio harveyi infection. Aquaculture. 2021;544:737158.

    Article  CAS  Google Scholar 

  42. Aly SM, Eissa AE, ElBanna NI, Albutti A. Efficiency of monovalent and polyvalent Vibrio alginolyticus and Vibrio Parahaemolyticus vaccines on the immune response and protection in gilthead sea bream, Sparus aurata (L.) against vibriosis. Fish Shellfish Immunol. 2021;111:145–51.

    Article  CAS  PubMed  Google Scholar 

  43. Vacca F, Sala C, Rappuoli R. Monoclonal antibodies for bacterial pathogens: mechanisms of action and engineering approaches for enhanced effector functions. Biomedicines. 2022;10(9):2126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Erfanmanesh A, Khanzadeh M, Beikzadeh B. Field study of Streptococcosis/Lactococosis and yersiniosis vaccine effectiveness in immunogenicity and survival rate of rainbow trout (Oncorhynchus mykiss). Fisheries Sci Technol. 2023;12(4):358–70.

    Google Scholar 

  45. Grant KR. Fish hematology and associated disorders. Vet Clin Exot Anim Pract. 2015;18:83–103.

    Article  Google Scholar 

  46. Hoseinifar SH, Khalili M, Rufchaei R, Raeisi M, Attar M, Cordero H, et al. Effects of date palm fruit extracts on skin mucosal immunity, immune related genes expression and growth performance of common carp (Cyprinus carpio) fry. Fish Shellfish Immunol. 2015;47:706–11.

    Article  CAS  PubMed  Google Scholar 

  47. Yonar SM. Growth performance, haematological changes, immune response, antioxidant activity and disease resistance in rainbow trout (Oncorhynchus mykiss) fed diet supplemented with ellagic acid. Fish Shellfish Immunol. 2019;95:391–8.

    Article  Google Scholar 

  48. Ross NW, Firth KJ, Wang A, Burka JF, Johnson SC. Changes in hydrolytic enzyme activities of naive Atlantic salmon Salmo salar skin mucus due to infection with the salmon louse Lepeophtheirus salmonis and cortisol implantation. Dis Aquat Organ. 2000;41:43–51.

    Article  CAS  PubMed  Google Scholar 

  49. Dezfuly ZT, Alishahi M, Ghorbanpoor M, Tabandeh MR, Mesbah M. Immunogenicity and protective efficacy of Yersinia ruckeri lipopolysaccharide (LPS), encapsulated by alginate-chitosan micro/nanoparticles in rainbow trout (Oncorhyncus Mykiss). Fish Shellfish Immunol. 2020;104:25–35.

    Article  CAS  PubMed  Google Scholar 

  50. Budiño B, Cal RM, Piazzon MC, Lamas J. The activity of several components of the innate immune system in diploid and triploid turbot. Comp Biochem Physiol Part Mol Integr Physiol. 2006;145:108–13.

    Article  Google Scholar 

  51. Skov J, Chettri JK, Jaafar RM, Kania PW, Dalsgaard I, Buchmann K. Effects of soluble immunostimulants on mucosal immune responses in rainbow trout immersion-vaccinated against Yersinia ruckeri, Aquaculture. 2018; 492, 237–46.

Download references

Acknowledgements

We sincerely thank ACECR for funding this research.

Funding

This research was funded by ACECR.

Author information

Authors and Affiliations

  1. Animal Biological Product Research Group, Academic Center for Education, Culture and Research (ACECR), Tehran Organization, Tehran, Iran

    Ahmad Erfanmanesh & Majid Khanzadeh

  2. Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran

    Babak Beikzadeh

  3. Department of Fisheries, Faculty of Fisheries and Environmental Sciences, Gorgan University of Agricultural Sciences and Natural Resources, Gorgan, Iran

    Majid Khanzadeh

  4. Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

    Mojtaba Alishahi

  5. Centre of Excellence for Warm Water Fish Health and Disease, Shahid Chamran University of Ahvaz, Ahvaz, Iran

    Mojtaba Alishahi

Authors
  1. Ahmad Erfanmanesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Babak Beikzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Majid Khanzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mojtaba Alishahi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.E: Conceptualization and study design, vaccine preparation, vaccine injection and immersion. B.B: Conceptualization and study design, blood, plasma, and immunological parameters analysis, manuscript drafting. M.K: Conceptualization and study design, Formal analysis, vaccine preparation, vaccine injection and immersion, writing an original draft, data analysis and manuscript drafting. M.A: Fish culture and sampling. All authors reviewed the manuscript.

Corresponding author

Correspondence to Majid Khanzadeh.

Ethics declarations

Ethical approval

All experiments were performed following the protocol approved by the Committee of Ethics of the Faculty of Sciences, University of Tehran (357; 8 November 2000).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erfanmanesh, A., Beikzadeh, B., Khanzadeh, M. et al. Immuno-protective response of Asian seabass (Lates calcarifer) to inactivated vaccines against Streptococcus iniae and Vibrio harveyi. BMC Vet Res 20, 89 (2024). https://doi.org/10.1186/s12917-024-03935-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12917-024-03935-x

Keywords

BMC Veterinary Research

ISSN: 1746-6148

Contact us